The variables time since diagnosis, metabolic risk factors (obesity, waist circumference, MetS), liver-related comorbidities (SLD, AF), T2DM-related comorbidities (CVD, retinopathy, polyneuropathy, and DFS), and treatment with insulin were all associated with a lower HRQL in the univariable analysis. This evidence concerns the gene INS and type 2 diabetes mellitus.